Explore 3 Stock Ideas & Industry Insights Download Free Report

Oscar Health Inc

Company price
31.705 USD 1.05 ( 3.44%)
Last update at 2026-11-09T18:14:00Z
VOLUME
1989584
Market Cap
10012.44M
P/E
25.95

Momentum Score

…

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
31.05
Low
32.00
High
52 Week Price Range
10.69
Low
34.48
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Oscar Health is a technology-oriented health insurer offering individual, small-group and Medicare Advantage plans alongside a digital care-navigation and claims platform. Long-term growth drivers include expansion in Medicare Advantage and employer channels, scaling its tech-enabled distribution and care-management capabilities, and potential underwriting improvements as membership mix evolves. Investors may find it attractive because the company appears positioned to leverage data and a consumer-focused platform to improve engagement and unit economics.
Key investment risks include persistent underwriting losses and medical-cost inflation, intense competition from large national insurers, regulatory and reimbursement changes, and potential capital or execution challenges.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
30.65
Dividend Yield
-
Revenue TTM
15318.63M
Revenue Per Share
53.60
Gross Profit TTM
3087.93M
Debt / Equity
0.44
ROE
34.26%
Net Debt
-2344.06M
ROCE
-28.71%
Diluted EPS TTM
1.25

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -437.30M 33.43M -267.30M -610.08M -570.58M
Minority interest -0.25M -0.69M 0.57M 3.28M -1.18M
Net income -443.15M 25.43M -270.73M -609.55M -571.43M
Selling general administrative 2049.87M 1755.94M 339.72M 309.78M 265.08M
Selling and marketing expenses - - 65.75M - -
Gross profit 1682.40M 1844.97M 5862.87M 4125.58M 1920.96M
Reconciled depreciation 28.89M 32.15M 26.69M 15.28M 14.61M
Ebit -419.94M 57.16M -235.62M -584.17M -577.06M
Ebitda -391.05M 89.31M -235.62M -568.89M -562.46M
Depreciation and amortization 28.89M 32.15M 30.69M 15.28M 14.61M
Non operating income net other - - - - -21.38M
Operating income -396.36M 57.27M -235.62M -584.17M -577.06M
Other operating expenses 12097.78M 9120.30M 6098.48M 4735.66M 2491.54M
Interest expense 17.60M 23.73M 24.60M 22.62M 4.72M
Tax provision 5.61M 7.30M 3.38M -0.52M 0.85M
Interest income - - - 31.31M 10.25M
Net interest income -17.60M -23.73M -24.52M -22.62M -4.72M
Income tax expense 5.61M 7.30M 3.29M -0.52M 0.85M
Total revenue 11701.43M 9177.56M 5862.87M 4125.58M 1920.96M
Total operating expenses 2078.76M 1787.71M 6098.48M 4553.51M -2498.02M
Cost of revenue 10019.02M 7332.59M 4643.03M - -
Total other income expense net -40.94M -23.84M -31.68M -25.90M 6.48M
Net income from continuing ops -442.90M 26.12M -347.32M -609.55M -571.43M
Net income applicable to common shares - - - -606.27M -572.61M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 6325.41M 4840.50M 3601.48M 4526.60M 3321.65M
Other current assets 180.15M 377.64M 299.68M 1165.67M 614.85M
Total liab 5344.68M 3824.07M 2795.36M 3634.20M 440.02M
Total stockholder equity 977.65M 1013.59M 803.97M 890.38M 1387.23M
Other current liab 4962.34M 1773.62M 2094.62M 2538.43M -440.02M
Common stock 0.00M 0.00M 0.00M 0.00M 0.00M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -3294.43M -2851.28M -2876.72M -2605.99M -1999.71M
Other liab - - - 0.10M 76.84M
Other assets - - 241.19M 4526.60M 817.80M
Cash 2774.15M 1527.19M 1870.32M 1558.60M 1103.99M
Total current liabilities 4862.59M 3171.70M 2429.01M 3263.92M 440.02M
Net debt -2344.06M -1227.63M -1571.54M -1260.60M -1103.99M
Short long term debt total 430.10M 299.56M 298.78M 298.00M 297.42M
Other stockholder equity 4254.05M 3866.69M 3679.37M 3506.08M 68.96M
Property plant equipment - - - 59.89M 46.61M
Total current assets 4613.40M 2845.17M 2819.91M 4121.56M 1870.15M
Long term investments 1216.46M 624.46M 689.83M 1397.29M 587.09M
Net tangible assets - - - 890.38M 1387.23M
Short term investments 1216.46M 624.46M 689.83M 1397.29M 587.09M
Net receivables 442.64M 315.89M 201.27M 1159.22M 179.07M
Long term debt 430.10M 299.56M 298.78M 298.00M -
Inventory - - -3054.54M -1159.22M -614.85M
Accounts payable -99.75M 1398.08M 334.39M 725.49M 440.02M
Noncontrolling interest in consolidated entity - - - 2.02M 5.29M
Accumulated other comprehensive income 18.03M -1.83M 1.31M -9.71M -3.67M
Common stock total equity - - - 0.00M 0.00M
Retained earnings total equity - - - -2605.99M -1999.71M
Treasury stock - - - -2.92M -2.92M
Non currrent assets other 152.67M 113.28M 113.14M -1052.13M -633.70M
Non current assets total 1712.01M 1995.32M 540.38M 405.05M 633.70M
Long term debt total - - - 298.00M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -208.96M -1387.43M -301.97M -226.52M -755.30M
Change to liabilities - - - 259.15M 101.76M
Total cashflows from investing activities -241.06M -1387.43M 577.19M -226.52M -774.51M
Net borrowings 410.00M 0.00M 0.00M 297.96M -153.17M
Total cash from financing activities 399.21M 68.39M 6.45M 301.11M 1238.71M
Change to operating activities - - - 874.28M 212.89M
Net income -442.90M 26.12M -270.59M -609.55M -571.43M
Change in cash 1253.01M -340.85M 311.47M 454.94M 282.45M
Begin period cash flow 1551.12M 1891.97M 1580.50M 1125.56M 843.11M
End period cash flow 2804.12M 1551.12M 1891.97M 1580.50M 1125.56M
Total cash from operating activities 1094.85M 978.19M -272.16M 380.35M -181.75M
Issuance of capital stock - - 0.00M 0.00M 1348.32M
Depreciation 28.89M 32.15M 30.69M 15.28M 14.61M
Other cashflows from investing activities 4.28M 3.93M -2.28M 1.12M 6.67M
Change to inventory - - -477.15M - -
Change to account receivables 98.57M -177.52M 636.23M -538.96M 80.45M
Sale purchase of stock - - - 3.15M 1404.88M
Other cashflows from financing activities -4.04M 68.39M 2.49M 299.81M 43.56M
Change to netincome - - - 113.44M 128.23M
Capital expenditures 36.37M 27.90M 25.58M 29.01M 25.89M
Change receivables - - - -538.96M 78.53M
Cash flows other operating - - - 1137.80M 260.81M
Cash and cash equivalents changes - - - 454.94M 282.45M
Change in working capital 1459.00M 838.86M -192.09M 857.99M 247.70M
Stock based compensation 87.65M 109.82M 159.68M 112.33M 86.30M
Other non cash items -40.24M -26.42M 0.09M 4.47M 41.19M
Free cash flow 1058.48M 950.30M -297.74M 351.34M -207.63M

Peer Comparison*

Sector: Healthcare Industry: Healthcare Plans

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
OSCR
Oscar Health Inc
1.05
3.44%
31.70 25.95 588.24 0.65 5.08 0.44
UNH
UnitedHealth Group Incorporated
4.39
1.11%
398.54 22.57 18.38 1.33 5.65 1.38
CVS
CVS Health Corp
1.70
2.03%
85.55 55.65 10.80 0.25 1.32 0.42
ELV
Elevance Health Inc
-1.89
0.44%
423.73 18.47 14.58 0.45 2.05 0.56
CI
The Cigna Group
3.67
1.25%
297.25 11.94 8.68 0.27 1.80 0.36

Profile*

Oscar Health Inc

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

75 Varick Street, New York, NY, United States, 10013

646 403 3677

2305

Name Title Year Born
Mr. Mario Tobias Schlosser Co-Founder, CEO & Director 1979
Mr. Joshua Kushner Co-Founder & Vice Chairman 1985
Mr. Siddhartha Sankaran Interim CFO & Director 1978
Mr. Richard Scott Blackley CPA, CPA Chief Transformation Officer 1968
Ms. Alessandrea Corinne Quane Exec. VP & Chief Insurance Officer 1970
Ms. Victoria Baltrus Chief Accounting Officer 1970
Cornelia Miller VP of Investor Relations NA
Ms. Ranmali Bopitiya Chief Legal Officer NA
Mr. Joel I. Klein Sr. Advisor 1947
Dr. Dennis Weaver M.D. Chief Clinical Officer 1961

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…